|
Genetic Analysis of Myeloproliferative Disease
|
3R01CA076167-14S1
|
$24,361
|
$24,361
|
COWELL, JOHN
|
AUGUSTA UNIVERSITY
|
|
Genetic Analysis of Myeloproliferative Disease
|
5R01CA076167-14
|
$307,800
|
$307,800
|
COWELL, JOHN
|
AUGUSTA UNIVERSITY
|
|
Impact of aging on the outcomes of a mouse model of chronic myeloid leukemia
|
5UH2CA213385-02
|
$49,295
|
$49,295
|
CHEN, WENYONG
|
BECKMAN RESEARCH INSTITUTE/CITY OF HOPE
|
|
Targeting PML for Leukemia Therapy
|
5R01CA142874-07
|
$465,791
|
$465,791
|
PANDOLFI, PIER PAOLO
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
SPORE in Myeloid Malignancies
|
1P50CA206963-01A1
|
$2,185,000
|
$262,200
|
EBERT, BENJAMIN
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Cancer Center Support Grant
|
3P30CA013696-43S1
|
$120,000
|
$1,200
|
ABATE-SHEN, CORY
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
Cancer Center Support Grant
|
3P30CA013696-43S2
|
$60,000
|
$600
|
ABATE-SHEN, CORY
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
Cancer Center Support Grant
|
3P30CA013696-43S3
|
$118,652
|
$1,187
|
ABATE-SHEN, CORY
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
Cancer Center Support Grant
|
3P30CA013696-43S4
|
$199,541
|
$1,995
|
ABATE-SHEN, CORY
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
Cancer Center Support Grant
|
5P30CA013696-43
|
$3,792,720
|
$37,927
|
ABATE-SHEN, CORY
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
Role of autophagy in normal and transformed hematopoietic stem cells
|
7R01CA184014-04
|
$332,000
|
$332,000
|
PASSEGUE, EMMANUELLE
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
The Role of EglN1 and HIF in Normal Hematopoiesis and in Leukemia
|
5R00CA181488-04
|
$249,000
|
$249,000
|
LOSMAN, JULIE
|
DANA-FARBER CANCER INST
|
|
Cancer Center Support Grant
|
3P30CA015704-42S1
|
$249,999
|
$2,500
|
GILLILAND, D
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Cancer Center Support Grant
|
3P30CA015704-42S2
|
$125,000
|
$1,250
|
GILLILAND, D
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Cancer Center Support Grant
|
3P30CA015704-42S3
|
$58,085
|
$581
|
GILLILAND, D
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Cancer Center Support Grant
|
3P30CA015704-42S4
|
$70,220
|
$702
|
GILLILAND, D
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Cancer Center Support Grant
|
5P30CA015704-42
|
$9,559,285
|
$95,593
|
GILLILAND, D
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Single-Cell Methods for Analysis of Clonal Heterogeneity and Evolution in Cancer
|
5R01CA175215-05
|
$579,042
|
$579,042
|
RADICH, JERALD
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Prodrug treatment for CML
|
1R43CA224731-01
|
$284,778
|
$284,778
|
WERNER, MILTON
|
INHIBIKASE THERAPEUTICS
|
|
Improving targeted therapies through functional genomic approaches
|
5F31CA189437-03
|
$21,152
|
$21,152
|
WANG, TIM
|
MASSACHUSETTS INSTITUTE OF TECHNOLOGY
|
|
Cytotoxicity of MLN4924 in Acute Myeloid Leukemia
|
5F30CA183507-04
|
$23,878
|
$11,939
|
KNORR, KATHERINE
|
MAYO CLINIC ROCHESTER
|
|
Stopping Tyrosine Kinase Inhibitors in CML Patients (Stop-TKIs)
|
5R01CA184798-04
|
$257,562
|
$257,562
|
ATALLAH, EHAB
|
MEDICAL COLLEGE OF WISCONSIN
|
|
Sphingolipid Signaling in Mammals
|
ZIA BC 011187
|
$591,339
|
$236,536
|
Acharya, Jairaj
|
CCR (NCI)
|
|
Natural History Study of the Complications Associated with Allogeneic HCT
|
ZIA BC 011742
|
$269,487
|
$26,949
|
Gea-Banacloche, Juan
|
CCR (NCI)
|
|
Molecular-Cellular Regulation of Hematopoietic Stem Cells
|
ZIA BC 010001
|
$834,114
|
$208,528
|
Keller, Jonathan
|
CCR (NCI)
|
|
Transcription and Splicing Dynamics in Single Cells
|
ZIA BC 011383
|
$950,432
|
$95,043
|
Larson, Daniel
|
CCR (NCI)
|
|
Study of the Roles of SDF1 and CXCR4 in Hematopoiesis
|
ZIA BC 010782
|
$380,715
|
$95,179
|
Tosato, Giovanna
|
CCR (NCI)
|
|
The role of Sin3B in normal and malignant hematopoietic stem cell functions
|
5F30CA203047-02
|
$49,044
|
$49,044
|
CANTOR, DAVID
|
NEW YORK UNIVERSITY SCHOOL OF MEDICINE
|
|
Mechanisms of Leukemogenesis in Down Syndrome
|
2R01CA101774-15
|
$336,656
|
$336,656
|
CRISPINO, JOHN
|
NORTHWESTERN UNIVERSITY AT CHICAGO
|
|
The role of ICSBP in the pathogenesis of chronic myeloid leukemia
|
5R01CA174205-05
|
$320,588
|
$320,588
|
EKLUND, ELIZABETH
|
NORTHWESTERN UNIVERSITY AT CHICAGO
|
|
Spatio-Temporal Organization of Chromatin and Information Transfer in Cancer
|
5U54CA193419-03
|
$1,762,723
|
$810,853
|
O'HALLORAN, THOMAS
|
NORTHWESTERN UNIVERSITY AT CHICAGO
|
|
The Robert H. Lurie Comprehensive Cancer Center
|
3P30CA060553-23S1
|
$204,369
|
$8,175
|
PLATANIAS, LEONIDAS
|
NORTHWESTERN UNIVERSITY AT CHICAGO
|
|
The Robert H. Lurie Comprehensive Cancer Center
|
3P30CA060553-23S2
|
$57,797
|
$2,312
|
PLATANIAS, LEONIDAS
|
NORTHWESTERN UNIVERSITY AT CHICAGO
|
|
The Robert H. Lurie Comprehensive Cancer Center
|
3P30CA060553-23S3
|
$79,482
|
$3,179
|
PLATANIAS, LEONIDAS
|
NORTHWESTERN UNIVERSITY AT CHICAGO
|
|
The Robert H. Lurie Comprehensive Cancer Center
|
5P30CA060553-23
|
$4,865,652
|
$194,626
|
PLATANIAS, LEONIDAS
|
NORTHWESTERN UNIVERSITY AT CHICAGO
|
|
Signal Transduction of Type 1 Interferons in Malignant Cells
|
5R01CA077816-19
|
$298,913
|
$298,913
|
PLATANIAS, LEONIDAS
|
NORTHWESTERN UNIVERSITY AT CHICAGO
|
|
Development of novel therapies for megakaryocytic malignancies
|
5R50CA211534-02
|
$130,753
|
$130,753
|
WEN, QIANG
|
NORTHWESTERN UNIVERSITY AT CHICAGO
|
|
OHSU Knight Cancer Institute
|
2P30CA069533-19
|
$2,310,000
|
$115,500
|
DRUKER, BRIAN
|
OREGON HEALTH & SCIENCE UNIVERSITY
|
|
Characterizing the landscape of resistance and persistence mechanisms in CML
|
2R01CA065823-21A1
|
$329,175
|
$329,175
|
DRUKER, BRIAN
|
OREGON HEALTH & SCIENCE UNIVERSITY
|
|
OHSU Knight Cancer Institute
|
3P30CA069533-19S1
|
$124,990
|
$6,250
|
DRUKER, BRIAN
|
OREGON HEALTH & SCIENCE UNIVERSITY
|
|
OHSU Knight Cancer Institute
|
3P30CA069533-19S2
|
$174,792
|
$8,740
|
DRUKER, BRIAN
|
OREGON HEALTH & SCIENCE UNIVERSITY
|
|
Pathogenic Mechanisms of CSF3R Mutations in Leukemia
|
5R00CA190605-04
|
$244,361
|
$244,361
|
MAXSON, JULIA
|
OREGON HEALTH & SCIENCE UNIVERSITY
|
|
Pathogenetic Mechanism and Clinical Targeting of CSF3R-Driven Cancer
|
5R01CA183974-04
|
$319,550
|
$319,550
|
TYNER, JEFFREY
|
OREGON HEALTH & SCIENCE UNIVERSITY
|
|
Characterization of CD99 as a Therapeutic Target in the Myelodysplastic Syndromes and Acute Myeloid Leukemia
|
1K08CA194275-01A1
|
$177,336
|
$177,336
|
CHUNG, STEPHEN
|
SLOAN-KETTERING INST CAN RESEARCH
|
|
Immunobiology for Marrow Allografts for Leukemia
|
5P01CA023766-38
|
$2,928,248
|
$204,977
|
O'REILLY, RICHARD
|
SLOAN-KETTERING INST CAN RESEARCH
|
|
Genomic profiling and development of murine models of transformation of MPNs
|
5K08CA188529-04
|
$178,200
|
$178,200
|
RAMPAL, RAAJIT
|
SLOAN-KETTERING INST CAN RESEARCH
|
|
Sphingolipids in Cancer Biology and Therapy
|
5P01CA097132-14
|
$1,301,994
|
$182,279
|
HANNUN, YUSUF
|
STATE UNIVERSITY NEW YORK STONY BROOK
|
|
Targeting the C/EBPalpha-Gfi-pathway in CML stem cells
|
5R01CA167169-05
|
$321,625
|
$321,625
|
CALABRETTA, BRUNO
|
THOMAS JEFFERSON UNIVERSITY
|
|
Translational Research in Cancer
|
3P30CA056036-18S1
|
$58,442
|
$1,753
|
KNUDSEN, KAREN
|
THOMAS JEFFERSON UNIVERSITY
|
|
Translational Research in Cancer
|
3P30CA056036-18S2
|
$117,000
|
$3,510
|
KNUDSEN, KAREN
|
THOMAS JEFFERSON UNIVERSITY
|
Total relevant funding to Chronic Myeloproliferative Disorders for this search: $16,629,705
|